AU2003294100A8 - Use of hyaluronic acid for respiratory disorders or the upper airways - Google Patents
Use of hyaluronic acid for respiratory disorders or the upper airwaysInfo
- Publication number
- AU2003294100A8 AU2003294100A8 AU2003294100A AU2003294100A AU2003294100A8 AU 2003294100 A8 AU2003294100 A8 AU 2003294100A8 AU 2003294100 A AU2003294100 A AU 2003294100A AU 2003294100 A AU2003294100 A AU 2003294100A AU 2003294100 A8 AU2003294100 A8 AU 2003294100A8
- Authority
- AU
- Australia
- Prior art keywords
- hyaluronic acid
- respiratory disorders
- upper airways
- airways
- respiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0214979A FR2847818B1 (en) | 2002-11-28 | 2002-11-28 | PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID |
FR02/14979 | 2002-11-28 | ||
PCT/FR2003/003507 WO2004050187A1 (en) | 2002-11-28 | 2003-11-27 | Use of hyaluronic acid for respiratory disorders or the upper airways |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003294100A1 AU2003294100A1 (en) | 2004-06-23 |
AU2003294100A8 true AU2003294100A8 (en) | 2004-06-23 |
Family
ID=32309802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003294100A Abandoned AU2003294100A1 (en) | 2002-11-28 | 2003-11-27 | Use of hyaluronic acid for respiratory disorders or the upper airways |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003294100A1 (en) |
FR (1) | FR2847818B1 (en) |
WO (1) | WO2004050187A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060183709A1 (en) * | 2005-02-15 | 2006-08-17 | Ahmad Alkayali | Preparation of low molecular weight hyaluronic acid as a food supplement |
ITMI20060742A1 (en) | 2006-04-13 | 2007-10-14 | Patrizia Pattini | ANTIBACTERIAL COMPOSITIONS FOR TREATMENT OF INFECTION OF HIGH AND LOW AIRCRAFT |
FR2919185B1 (en) * | 2007-07-23 | 2010-09-10 | Ard Sa | USE OF HYALURONIC ACID FOR THE PREPARATION OF COMPOSITIONS INTENDED TO IMPROVE THE CONDITION OF MUCOUS MEMBRANES |
IT1396468B1 (en) * | 2008-11-11 | 2012-12-14 | Farma Derma Srl | TOPIC USE OF HYALURONIC ACID FOR FILMOGEN ACTION IN PREPARATIONS FOR TREATMENT AND PROPHYLAXIS OF PATHOLOGIES OF THE RESPIRATORY PATHWAYS. |
EP2985019B1 (en) | 2014-08-16 | 2021-10-20 | Church & Dwight Co., Inc. | Nasal composition having anti-viral properties |
EP2985027B1 (en) | 2014-08-16 | 2021-03-31 | Church & Dwight Co., Inc. | Nasal composition comprising mixture of hyaluronic acids and saline solution |
EP3415154A1 (en) | 2017-06-16 | 2018-12-19 | Sofibel S.A.S. | Nasal composition |
WO2023079072A1 (en) | 2021-11-05 | 2023-05-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3310994B2 (en) * | 1991-07-03 | 2002-08-05 | 電気化学工業株式会社 | Allergy treatment |
US5633003A (en) * | 1994-03-31 | 1997-05-27 | Cantor; Jerome O. | Use of intratracheally administered hyaluronic acid to ameliorate emphysema |
WO1999062546A1 (en) * | 1998-06-01 | 1999-12-09 | Chiron Corporation | Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
EP1292314A2 (en) * | 2000-05-23 | 2003-03-19 | The Trustees of Columbia University in the City of New York | Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans |
AU2002315330A1 (en) * | 2001-06-15 | 2003-01-02 | Exhale Therapeutics, Inc. | Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid |
-
2002
- 2002-11-28 FR FR0214979A patent/FR2847818B1/en not_active Expired - Lifetime
-
2003
- 2003-11-27 WO PCT/FR2003/003507 patent/WO2004050187A1/en not_active Application Discontinuation
- 2003-11-27 AU AU2003294100A patent/AU2003294100A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004050187A1 (en) | 2004-06-17 |
AU2003294100A1 (en) | 2004-06-23 |
FR2847818B1 (en) | 2008-04-04 |
FR2847818A1 (en) | 2004-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1400011I1 (en) | Novel medicaments for the treatment of chronic obstructive pulmonary diseases | |
AU2003291992A1 (en) | Phenylethanolamine derivatives for the treatment of respiratory diseases | |
HK1081173A1 (en) | Phenethanolamine derivative for the treatment of respiratory diseases | |
HK1171736A1 (en) | Substituted acids for the treatment of respiratory diseases | |
AU2003279338A1 (en) | Phenethanolamine derivatives for the treatment of respiratory diseases | |
PL1656346T3 (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
IL181049A0 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
AU2003285091A8 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
HK1102814A1 (en) | Novel hydantoin derivatives for the treatment of obstructive airway diseases | |
AU2003233583A8 (en) | Oral lactoferrin in the treatment of respiratory disorders | |
TWI372056B (en) | Novel medicament combinations for the treatment of respiratory diseases | |
IL178815A0 (en) | The treatment of respiratory disease | |
SI1530466T1 (en) | Use of Nintedanib for the treatment of lung fibrosis | |
AU2003286728A8 (en) | Compounds for the treatment of metabolic disorders | |
GB0410399D0 (en) | The treatment of respiratory disease | |
AU2003294100A8 (en) | Use of hyaluronic acid for respiratory disorders or the upper airways | |
HRP20041160A2 (en) | Novel combination for the treatment of airway disorders | |
AU2003205898A1 (en) | Combination therapy for respiratory disorders | |
AU2003273856A8 (en) | Vr1 antagonists for the treatment of urological disorders | |
HRP20041159A2 (en) | Combination for the treatment of airway disorders | |
AU2003269257A1 (en) | Use of cap-1 for the therapy of asthma | |
PL370839A1 (en) | Use of proton pump inhibitors for the treatment of airway disorders | |
GB0211414D0 (en) | Treatment of respiratory disorders | |
GB0224330D0 (en) | Treatment of respiratory disorders | |
GB0224328D0 (en) | Combination therapy for respiratory disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
TH | Corrigenda |
Free format text: IN VOL 18, NO 29, PAGE(S) 7783 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.), APPLICATION NO. 2003294100, UNDER INID (71) CORRECT THE NAME TO READ INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.) |